Digraph

Cefiderocol

FetrojaFETCROJA

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

2019-11 FDA approves cefiderocol complicated urinary tract infections
Cefiderocol Complicated urinary tract infections (cUTIs)United States Food and Drug Administration (FDA)
2020-06 FDA accepts cefiderocol sNDA for priority review
United States Food and Drug Administration (FDA)Cefiderocol
New Antibiotics Treat Select Resistant Infections
https://www.pharmacytimes.com/publications/health-system-edition/2020/May2020/new-antibiotics-treat-select-resistant-infections
Cefiderocol
Positive CHMP opinion for Shionogi's treatment of infections due to aerobic Gram-negative bacteria - Pharmafield
https://pharmafield.co.uk/pharma_news/positive-chmp-opinion-for-shionogis-treatment-of-infections-due-to-aerobic-gram-negative-bacteria/
Cefiderocol
Cefiderocol Now Available in the U.S
https://www.idse.net/Bacterial-Infections/Article/02-20/Cefiderocol-Now-Available-in-the-U.S/57395
Cefiderocol
Stewardship / Resistance Scan for Feb 25, 2020 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2020/02/stewardship-resistance-scan-feb-25-2020
Cefiderocol PLG0206 Peptide antibiotics
Two More Agents Bolster the Arsenal Against Gram-Negative Resistance
https://www.contagionlive.com/publications/contagion/2019/december/two-more-agents-bolster-the-arsenal-against-gramnegative-resistance
Cefiderocol Imipenem-cilastatin-relebactam
[Full text] Designing A Pathogen-Focused Study To Address The High Unmet Medical N | IDR
https://www.dovepress.com/designing-a-pathogen-focused-study-to-address-the-high-unmet-medical-n-peer-reviewed-fulltext-article-IDR
Carbapenem-resistant Enterobacteriaceae (CRE)Cefiderocol
Investigational antibiotic, Cefiderocol, receives U.S. FDA Advisory Committee recommendation for approval to treat complicated UTIs - Outbreak News Today
http://outbreaknewstoday.com/investigational-antibiotic-cefiderocol-receives-u-s-fda-advisory-committee-recommendation-for-approval-to-treat-complicated-utis-63891/
Cefiderocol
Stewardship / Resistance Scan for Oct 17, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-17-2019
Cefiderocol
FDA Panel Votes on Novel Antibiotic for Complicated UTI - MPR
https://www.empr.com/home/news/fda-panel-votes-on-novel-antibiotic-for-complicated-uti/
Cefiderocol
FDA Panel Recommends Cefiderocol for Complicated UTI
https://www.medscape.com/viewarticle/919979
Cefiderocol
FDA Advisory Committee Backs Cefiderocol Efficacy for cUTI 14-2
https://www.contagionlive.com/news/fda-advisory-committee-backs-cefiderocol-efficacy-for-cuti-142
Cefiderocol
U.S. FDA Advisory Committee Recommends Approval of Cefiderocol for Treatment of Complicated Urinary Tract Infections | Business Wire
https://www.businesswire.com/news/home/20191016005916/en/U.S.-FDA-Advisory-Committee-Recommends-Approval-Cefiderocol
Cefiderocol
Cefiderocol for Urinary Infections Set for FDA Advisory Review | Medpage Today
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/82754
Cefiderocol
What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
https://www.contagionlive.com/publications/contagion/2019/october/whats-new-from-the-clsi-subcommittee-on-antimicrobial-susceptibility-testing
Azithromycin CLSI Subcommittee on Antimicrobial Susceptibility Testing (AST)Cefiderocol Ceftazidime-avibactam Ceftriaxone Colistin Daptomycin Enterococcus faecalis Enterococcus faecium Meropenem-vaborbactam Plazomicin Polymyxin B Polymyxins
Stewardship / Resistance Scan for Oct 07, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-07-2019
Aminoglycosides Carbapenems Cefiderocol Chloramphenicol Colistin Extensively drug-resistant (XDR) Klebsiella pneumoniae Fosfomycin Quinolones Tigecycline
New Antibiotic Proves Mettle in Nosocomial Pneumonia | Medpage Today
https://www.medpagetoday.com/meetingcoverage/idweek/82591
Beta-lactamases Cefiderocol Meropenem
Cefiderocol Compared With Meropenem for Nosocomial Pneumonia Treatment
https://www.empr.com/home/news/cefiderocol-compared-with-meropenem-for-nosocomial-pneumonia-treatment/
Cefiderocol Meropenem
Stewardship / Resistance Scan for Oct 03, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-03-2019
Cefiderocol
Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting
https://finance.yahoo.com/news/shionogi-present-cefiderocol-cot-143-143500692.html
Cefiderocol Pharmaceutical makers, antibiotic resistance and the development of new drugs
Shionogi announces data demonstrating potent in vitro activity of cefiderocol against the most critical priority gram-negative bacterial pathogens - PharmiWeb.com
https://www.pharmiweb.com/press-release/2019-04-17/shionogi-announces-data-demonstrating-potent-in-vitro-activity-of-cefiderocol-against-the-most-critical-priority-gram-negative-bacterial-pathogens
Antibiotic resistance and the development of new drugs Cefiderocol
With Potent In Vitro Activity, Cefiderocol a Promising Option for Treating Resistance
https://www.contagionlive.com/news/with-potent-in-vitro-activity-cefiderocol-a-promising-option-for-treating-resistance
Antibiotic resistance and the development of new drugs Cefiderocol
Shionogi Announces Data Demonstrating Potent in Vitro Activity of Cefiderocol against the Most Critical Priority Gram-Negative Bacterial Pathogens - DutchNews.nl
https://www.dutchnews.nl/news/businesswire/shionogi-announces-data-demonstrating-potent-in-vitro-activity-of-cefiderocol-against-the-most-critical-priority-gram-negative-bacterial-pathogens/
Antibiotic resistance and the development of new drugs Cefiderocol
Shionogi Announces Data Demonstrating Potent in Vitro Activity of Cefiderocol against the Most Critical Priority Gram-Negative Bacterial Pathogens | Business Wire
https://www.businesswire.com/news/home/20190414005009/en/Shionogi-Announces-Data-Demonstrating-Potent-Vitro-Activity
Antibiotic resistance and the development of new drugs Cefiderocol